Slow in OTC drug business worsen management hardship.

The management performance of the listed drug makers having a fiscal year ended in March was remarkably depressed largely stemming from poor sale performances of the non-prescription drugs.

According to Yakup Press survey, the total sales of those companies during the 2003 fiscal year (from April 1, 2003 to Mar. 31, 2004) unveiled 642,900 million won, which was 6.14% up from the previous yea...